Volume 19, Issue 9, Pages (September 2012)

Slides:



Advertisements
Similar presentations
In Vitro Discriminative Antipseudomonal Properties Resulting from Acyl Substitution of N-Terminal Sequence of Dermaseptin S4 Derivatives  Keren Marynka,
Advertisements

Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Volume 21, Issue 1, Pages (January 2014)
Volume 11, Issue 8, Pages (August 2004)
Volume 21, Issue 1, Pages (January 2014)
The Small-Molecule Iron Transport Inhibitor Ferristatin/NSC Promotes Degradation of the Transferrin Receptor  Lior Horonchik, Marianne Wessling-Resnick 
Colleen T. Skau, David R. Kovar  Current Biology 
Kinetic Analysis of High Affinity Forms of Interleukin (IL)-13 Receptors: Suppression of IL-13 Binding by IL-2 Receptor γ Chain  Vladimir A. Kuznetsov,
Volume 15, Issue 9, Pages (September 2008)
Rapid Secretion of Interleukin-1β by Microvesicle Shedding
Volume 19, Issue 8, Pages (August 2012)
Volume 18, Issue 8, Pages (August 2011)
Biofilm Inhibitors that Target Amyloid Proteins
Volume 19, Issue 7, Pages (July 2012)
Volume 22, Issue 10, Pages (October 2015)
Quantum Dot-Mediated Detection of γ-Aminobutyric Acid Binding Sites on the Surface of Living Pollen Protoplasts in Tobacco  Guanghui Yu, Jiangong Liang,
Volume 22, Issue 6, Pages (June 2015)
Small Molecule Fluoride Toxicity Agonists
Volume 24, Issue 8, Pages e7 (August 2017)
Discovery of Peptoid Ligands for Anti-Aquaporin 4 Antibodies
Small Molecule Fluoride Toxicity Agonists
Volume 19, Issue 4, Pages (April 2012)
Structure-Guided Design of Fluorescent S-Adenosylmethionine Analogs for a High- Throughput Screen to Target SAM-I Riboswitch RNAs  Scott F. Hickey, Ming C.
Actin Cytoskeleton-Dependent Dynamics of the Human Serotonin1A Receptor Correlates with Receptor Signaling  Sourav Ganguly, Thomas J. Pucadyil, Amitabha.
Volume 22, Issue 3, Pages (March 2015)
Volume 18, Issue 9, Pages (September 2011)
Specific Synergy of Multiple Substrate–Receptor Interactions in Platelet Thrombus Formation under Flow  Brian Savage, Fanny Almus-Jacobs, Zaverio M Ruggeri 
Volume 22, Issue 5, Pages (May 2015)
Volume 18, Issue 9, Pages (September 2011)
Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor  Donata M. Paresce, Richik N. Ghosh, Frederick.
Volume 19, Issue 12, Pages (December 2012)
Volume 15, Issue 13, Pages (July 2005)
Volume 19, Issue 6, Pages (June 2012)
Johnson Cheung, Michael E.P. Murphy, David E. Heinrichs 
Volume 19, Issue 7, Pages (July 2012)
Volume 16, Issue 12, Pages (December 2009)
Identification of Small Molecule Inhibitors that Distinguish between Non-Transferrin Bound Iron Uptake and Transferrin-Mediated Iron Transport  Jing Xu.
Volume 25, Issue 10, Pages e5 (October 2018)
Volume 15, Issue 4, Pages (April 2008)
Volume 14, Issue 10, Pages (October 2007)
Volume 20, Issue 1, Pages (January 2013)
Targeting MgrA-Mediated Virulence Regulation in Staphylococcus aureus
Blends of Non-caloric Sweeteners Saccharin and Cyclamate Show Reduced Off-Taste due to TAS2R Bitter Receptor Inhibition  Maik Behrens, Kristina Blank,
Volume 14, Issue 8, Pages (August 2007)
An Electrophoretic Mobility Shift Assay Identifies a Mechanistically Unique Inhibitor of Protein Sumoylation  Yeong Sang Kim, Katelyn Nagy, Samantha Keyser,
Adenosine Receptors as Mediators of Both Cell Proliferation and Cell Death of Cultured Human Melanoma Cells  Stefania Merighi, Prisco Mirandola, Daniela.
Volume 19, Issue 8, Pages (August 2012)
Volume 21, Issue 8, Pages (August 2014)
Cristina Esteva-Font, Puay-Wah Phuan, Marc O. Anderson, A.S. Verkman 
Volume 22, Issue 11, Pages (November 2015)
Volume 13, Issue 4, Pages (April 2006)
Volume 18, Issue 2, Pages (February 2011)
Volume 17, Issue 10, Pages (October 2010)
Volume 17, Issue 8, Pages (August 2010)
Volume 18, Issue 5, Pages (May 2011)
Jillian G. Baker, Stephen J. Hill  Trends in Pharmacological Sciences 
Volume 18, Issue 9, Pages (September 2011)
Olesya A. Ulanovskaya, Jiayue Cui, Stephen J. Kron, Sergey A. Kozmin 
Volume 12, Issue 6, Pages (June 2005)
Volume 21, Issue 9, Pages (September 2014)
Volume 19, Issue 8, Pages (August 2012)
Volume 12, Issue 9, Pages (September 2005)
Rapid Secretion of Interleukin-1β by Microvesicle Shedding
Volume 23, Issue 7, Pages (July 2016)
Volume 18, Issue 11, Pages (November 2011)
Volume 21, Issue 3, Pages (March 2014)
Volume 24, Issue 3, Pages (March 2017)
Volume 17, Issue 8, Pages (August 2010)
Volume 21, Issue 9, Pages (September 2014)
Volume 15, Issue 11, Pages (November 2008)
Presentation transcript:

Volume 19, Issue 9, Pages 1105-1115 (September 2012) Fragment Screening at Adenosine-A3 Receptors in Living Cells Using a Fluorescence- Based Binding Assay  Leigh A. Stoddart, Andrea J. Vernall, Jessica L. Denman, Stephen J. Briddon, Barrie Kellam, Stephen J. Hill  Chemistry & Biology  Volume 19, Issue 9, Pages 1105-1115 (September 2012) DOI: 10.1016/j.chembiol.2012.07.014 Copyright © 2012 Elsevier Ltd Terms and Conditions

Chemistry & Biology 2012 19, 1105-1115DOI: (10. 1016/j. chembiol. 2012 Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 1 Pharmacologic Characterization of CA200645 (A) The fluorescent ligand CA200645. (B) Effect of increasing concentrations of the agonist, NECA, in the absence (•) and presence of 10 nM (▪), 100 nM (▲), and 1 μM (♦) CA200645 on the SPAP response to 1 μM FSK in cells expressing A3AR. Data are normalized to the response to 1 μM FSK and each data point represents mean ± SEM from three separate experiments performed in triplicate. (C) CHO cells expressing the A3AR or A3-YFP labeled with 25 nM CA200645, with and without preincubation with 100 nM MRS1220. Images shown are from a single experiment representative of three performed. (D) Association and dissocation kinetics of 25 nM CA200645. CHO A3AR cells were exposed to 25 nM CA200645 and confocal images were taken every 2 s for 20 min. Cells were washed with HBSS and images taken for a further 20 min. Data represents mean ± SEM from four separate experiments in which each replicate reflects the fluorescence intensity from the plasma membrane of ten cells. See also Figure S1. Chemistry & Biology 2012 19, 1105-1115DOI: (10.1016/j.chembiol.2012.07.014) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 2 High-Content Screening Allows Competition Binding Curves to be Generated and Affinity Values Obtained at Both the A3AR and A1AR (A) Montage of one plate of images obtained using high-content screening in CHO CRE-SPAP A3AR cells. The two blank wells at the bottom of the first column are where the autofocusing of the plate was performed. (B) Competition curves at the A3AR generated from the total image intensity for five adenosine receptor antagonists. (C) Correlation between pKi values obtained using HCS and pKB values obtained in a functional SPAP assay. (D) Competition curves at the A3AR for five different adenosine receptor agonists. (E) Competition curves at the A1AR generated from the total image intensity in CHO-A1 cells for five adenosine receptor antagonists. Data are normalized to the maximal intensity observed per experiment and each data point represents the mean ± SEM from four (D and E) or five (B) experiments performed in duplicate. See also Figure S2. Chemistry & Biology 2012 19, 1105-1115DOI: (10.1016/j.chembiol.2012.07.014) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 3 Simultaneous Measurement of Ligand Binding and Receptor Internalization Cells expressing A3-YFP were treated with increasing concentrations of the agonists HEMADO and 2-Cl IB-MECA and the antagonist MRS1220 for 30 min prior to the addition of 25 nM CA200645. CA200645 and YFP images were then obtained on the ImageXpress Ultra confocal plate reader after a further 30 min. Representative YFP images show that in the absence of ligand A3-YFP is clearly expressed at the cell surface and no change in localization is observed in the presence of MRS1220 (A). Clear redistribution of A3-YFP is observed in the presence of high concentrations of HEMADO or 2-Cl IB-MECA. Total image intensity for CA200645 images was obtained and granularity analysis was performed on YFP image. Competition curves were obtained with for MRS1220 (▪), HEMADO (□), and 2-Cl IB-MECA (•) (B) but only the agonists, HEMADO and 2-Cl IB-MECA, caused an increase in granule count (C). Data are normalized to the maximal intensity (B) observed or 10 μM 2-Cl IB-MECA response (C) per experiment and each data point represents the mean ± SEM from four experiments performed in duplicate. Chemistry & Biology 2012 19, 1105-1115DOI: (10.1016/j.chembiol.2012.07.014) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 4 Displacement of CA200645 Binding by Fragments Demonstrates that a Wide Range of Affinities Can Be Determined at the A3AR (A) The high-affinity A3AR antagonist 1 was deconstructed into progressively lower molecular weight molecules 2–7, and the pKi values determined. (B) Competition curves at the A3AR generated from the total image intensity. Data are normalized to the maximal intensity observed per experiment and each data point represents mean ± SEM from at least three separate experiments performed in duplicate. See also Figure S3. Chemistry & Biology 2012 19, 1105-1115DOI: (10.1016/j.chembiol.2012.07.014) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 5 Screening a Commercial Fragment Library Identifies Hits with Affinities of Less Than 10 μM A total of 248 compounds from a Maybridge “Rule of Three” fragment library at a single concentration of 1 mM were tested for their ability to inhibit the binding of CA200645 at the A3AR. (A) A representative selection of the inhibition observed with 25 fragments and the controls, 1 μM MRS1220 (gray bars) and 1% DMSO (white bars). Any fragments that inhibited CA200645 binding to within 10% of that observed with MRS1220 were defined as hits and full concentration response curves defined as described in Figure 1. (B) Concentration response curves of the top six fragment hits at the A3AR. Each data point represents mean ± SEM from four separate experiments performed in duplicate. (C) The chemical structure of the top six fragment hits with mean ± SEM pKi values shown below the structure. (D) Representative images from A3-YFP expressing cells treated with 1 mM for 1 hr at 37°C of the top six compounds. See also Tables S1 and S2. Chemistry & Biology 2012 19, 1105-1115DOI: (10.1016/j.chembiol.2012.07.014) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 6 Elaborated Derivates of DP 01095 Show Higher Affinity at the A3AR but Not at the A1AR (A) Structure of the top fragment hit (DP 01095) and two derivatives, 8 and 9. (B and C) These fragments were tested for their ability to inhibit the binding of CA200645 in cells expressing the A3AR (B) or A1AR (C). Each data point represents mean ± SEM from six (B) and four (C) experiments performed in duplicate. (D) Structure of three synthesized DP 01095 derivatives (10–12). (E and F) The ability of these three compounds to inhibit the binding of 25 nM CA200645 in cells expressing the A3AR (E) or A1AR (F) receptor is shown. The dashed lines show the curve obtained with DP 01095. Each data point represents mean ± SEM from four experiments performed in duplicate. See also Figure S4 and Table S3. Chemistry & Biology 2012 19, 1105-1115DOI: (10.1016/j.chembiol.2012.07.014) Copyright © 2012 Elsevier Ltd Terms and Conditions